NEW YORK (AP) -- A Senate report said Saturday that drug maker GlaxoSmithKline knew of possible heart attack risks tied to Avandia, its diabetes medication, years before such evidence became public....
By BARBARA ORTUTAY, Associated Press: Business
Sat, 02/20/2010 - 3:22pm
NEW YORK (AP) -- A Senate report said Saturday that drug maker GlaxoSmithKline knew of possible heart attack risks tied to Avandia, its diabetes medication, years before such evidence became public....